N/A
N=213
Mobile Diabetes Management
Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT01107015 ↗Enrolled (actual)
213
Serious AEs
0.0%
Results posted
Mar 2018
Primary outcome: Primary: HBA1c at One Year — 8.5; 7.7; 7.9; 7.9 percentage of HbA1c — p=0.027
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Tailored Patient Intervention (Device); Patient-physician intervention (Device); Patient and PCP intervention with analyzed data (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, Baltimore
- Primary completion
- Aug 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HBA1c at One Year |
8.5; 7.7; 7.9; 7.9 | 0.027 sig |
Summary
The Mobile Diabetes Intervention Study trial is evaluating a diabetes coaching system, using mobile phones and patient/ physician internet portals to allow patient-specific treatment and communication by their primary care physician. We hypothesize that timely information provided to patients and their physicians can result in reduction of A1c over 1 year.
Eligibility Criteria
Inclusion Criteria
- Type 2 diabetic [patient]
- A1c equal to or greater than 7.5 [patient]
- 18-64 years of age at time of recruitment [patient]
- Access to the internet (does not need to be at their home, elsewhere is fine e.g. work) [patient]
- E-mail account [patient]
- Must speak English [patient]
Exclusion Criteria
- No insulin pump [patient]
- No current alcohol or drug abuse- must be sober 1 year [patient]
- Not currently pregnant [patient]
- No terminal diagnosis [patient]
- No dementia or Alzheimer's [patient]
- No active chemotherapy [patient]
- No significant hearing impairment [patient]
- Poorly corrected vision that would impede use of phone [patient]
- No mute or aphasia [patient]
- No diagnosis of schizophrenia, bipolar disorder, or major psychosis [patient]
- No Medicaid or Medicare
- No uninsured
Data sourced from ClinicalTrials.gov (NCT01107015). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.